PregnancyMONARCHNCT02626351
Management and Optimization of Nutrition, Antenatal, Reproductive, Child Health & HIV Care
A study testing Quality Improvement and Baseline data collection (active comparator) in people with Pregnancy and HIV, run by University of KwaZulu at 1 site in South Africa.
Trial summary
This study evaluates the impact of a quality improvement (QI) intervention on maternal and child healthcare services in seven primary healthcare (PHC) clinics, in a rural setting of KwaZulu-Natal, South Africa. Read more about this study
- Who is it for?
- Ages 18 to 50 years, women onlyHealthy volunteers can take part
- What is being tested?
- Quality Improvement and Baseline data collection (active comparator)
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 3,172 participants
- Where
- 1 siteSouth Africa
- Study dates
- 15 Jul 2015to 30 Jan 2017
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 50 years
- Women only
- Healthy volunteers accepted
- Adult
Who may be able to join
- Currently postpartum: immediately post delivery OR 3-6 days postpartum OR 6 weeks postpartum; AND
- Lives in Africa Centre Demographic Surveillance Area (DSA); AND/OR
- Attended antenatal care (ANC) or postnatal care (PNC) in study intervention clinics
Who cannot join
- Below 18 years of age;
- Not postpartum;
- Does not live within Africa Centre DSA; AND
- Did not attend ANC or PNC at study intervention clinics
Trial locations and contacts
1 site in 1 country.
South Africa1 site
Africa Centre for Population Health
Mtubatuba, KwaZulu-Natal, 3935
About this study
Official title: Optimizing the Delivery of Maternal and Child Health Services to Strengthen the Primary Health Care System in Rural South Africa
This study evaluates the impact of a quality improvement (QI) intervention on maternal and child healthcare services in seven primary healthcare (PHC) clinics, in a rural setting of KwaZulu-Natal, South Africa.
Read the detailed description
INTRODUCTION TO QUALITY IMPROVEMENT Quality Improvement (QI), defined as "systematic and continuous actions that lead to measurable improvement in health care services and the health status of targeted patient groups" (IOM 2014) has roots in the consumer industry as far back as the 1920s. Data-driven structured process improvements have their origins in the consumer industry, particularly motor vehicles, and Avedis Donabedian first described a model for healthcare quality improvement in the 1960s which reflects the same process change model utilised in the consumer industry: the key elements being structures, processes and outcomes. Don Berwick and colleagues founded the Institute for Healthcare Improvement (IHI) in the 1990s, now a leading institution on QI worldwide. The QI approach or 'form' is structured and uses specific QI tools, whereas its application or 'function' is varied depending on selected process interventions and local context. Given the move towards rigorously improving quality of health care worldwide, QI methodology is increasingly gaining popularity not only in high-income settings but also in low- and middle-income countries (LMIC) including South Africa through Department of Health (DoH) commitments to improving quality of health care and reducing disparities thereof.
EVIDENCE BASE FOR QI Whereas QI is increasingly used worldwide including resource-rich settings and resource-limited settings, there is a paucity of scientific evidence assessing causal impact of QI on health outcomes, particularly the gold standard randomized controlled trial. Studies in resource-limited settings suggest a beneficial effect of QI on measured healthcare outcomes however none assessed QI rigorously as a single intervention.
GAPS IN THE PMTCT CASCADE AND INFANT NUTRITION Despite worldwide rollout of antiretroviral therapy (ART) and efforts to prevent mother-to-child transmission (PMTCT), there are still large gaps in coverage with approximately 240,000 infants vertically infected with HIV worldwide, 89% of whom were from the WHO Africa region. South Africa has a very high prevalence of HIV, with a national average of 30% amongst antenatal care (ANC) clients. In the Africa Centre Demographic Surveillance Area (DSA) located within the Hlabisa sub-district of uMkhanyakude district, the HIV prevalence amongst females of reproductive age (15-49 years) ranged from 20-45% in 2011.KwaZulu-Natal province had the highest prevalence of HIV amongst ANC clients of 37.4% in 2012. Furthermore, although KwaZulu-Natal (KZN) had the highest rate of ART coverage amongst HIV-infected pregnant women eligible for ART, the uMkhanyakude district in KZN had ART coverage of only 73% during the same period, far behind the national target of 90%.
Studies have shown inadequate virologic suppression amongst HIV-infected pregnant and breastfeeding (PBF) mothers, and inadequate repeat HIV testing of HIV-negative mothers during the PBF period. Surveillance of PBF mothers in Kenya, Malawi and South Africa demonstrated an HIV seroconversion rate of approximately 4%, illustrating the need to repeat HIV testing through pregnancy and breastfeeding in order to minimize risk of MTCT. Moreover the rate of virologic suppression amongst HIV-infected PBF women varied from 27% (in Kenya) to 72% in Malawi in the same study, and underscores the importance of virologic monitoring to reduce MTCT through virologic suppression. A study in Kenya demonstrated a repeat HIV testing rate of approximately 23% in HIV negative mothers. Given the risk of seroconversion during PBF, the World Health Organisation recommends repeat HIV screening during PBF in high prevalence settings. Although SA has achieved a commendable reduction in MTCT to 2.7% in 2011 at 6 weeks of age in line with the UNAIDS call for virtual elimination of MTCT by 2015, these gaps in PMTCT coverage increase the risk of undetected maternal HIV seroconversion and inadequate virologic suppression and therefore PMTCT achievements to date may be reversed without adequate intervention. Furthermore, given the fertility rate of the population, an MTCT rate of 2.7% with an antenatal HIV prevalence of 30% the number of new infant infections per year in South Africa is concerning high. Preliminary data from the Africa Centre suggest that less than 40% HIV-negative pregnant women undergo re-testing for HIV during pregnancy, whilst approximately 10-20% on lifelong ART (initiated prior to or during the current pregnancy) have virologic failure.
An important component on the agenda for reducing maternal morbidity and mortality is preventing unwanted pregnancies through better uptake of family planning methods. However limitations to contraceptive uptake include lack of knowledge and lack of access in resource-limited settings. According to UNFPA estimates, contraceptive prevalence in South Africa is approximately 65% despite free access to most methods.
Although replacement feeding of HIV-exposed infants might mitigate the risk of MTCT, in resource-limited settings with unreliable access to safe drinking water the high risk of childhood illnesses such as diarrhoea and pneumonia is associated with high rates of mortality. As under 5 childhood mortality in these settings can be reduced significantly by exclusive breastfeeding (EBF), the WHO recommends EBF for HIV-infected and HIV-uninfected mothers, whilst the importance of ART and virologic suppression are further emphasised. These recommendations are endorsed by the South African DoH however stigma associated with EBF by HIV-infected mothers often becomes a barrier to uptake of EBF in general. South Africa had the lowest rates of EBF in the world in 2012 at just 8%.
New South African DoH ART guidelines were implemented in January 2015, notably changing PMTCT guidance to Option B+ (lifelong ART for all pregnant women regardless of CD4 count). HIV screening every 3 months during PBF is also recommended due to the risk of seroconversions given the high prevalence of HIV in South Africa. Furthermore, viral load (VL) testing of PBF on ART is recommended, immediately for those already on ART prior to pregnancy and every 6 months thereafter (assuming VL results are <1000 copies/mL); newly diagnosed PBF women should receive a VL test 3 months after initiating ART and 6 monthly thereafter (assuming VL results are <1000 copies/mL).
THE CONTEXT OF ANTENATAL AND POSTNATAL CARE SERVICES The Africa Centre for Population Health is located in the Hlabisa sub-district of uMkhanyakude district in rural KwaZulu-Natal South Africa. The Africa Centre Demographic Surveillance Area (DSA) covers an area of 438 km2 and is home to the Africa Centre Household Demographic Surveillance System (HDSS), covering approximately 90,000 people from 11,000 households annually. The HDSS is a longitudinal cohort from the early 2000s and collects individual and household information on mortality, fertility, migration, health status and socio-economic data. This provides a nuanced understanding of the study population and enables linking of datasets.
There are 7 primary healthcare clinic (PHC) facilities which are nurse-led in the DSA, providing ANC, PNC and other medical services, and one local district hospital (Hlabisa hospital) which offers some tertiary care services including routine and emergency obstetric care. The number of deliveries occurring in Hlabisa sub-district is estimated at about 3000 per annum.
The local hospital also provides medical doctor support to the PHCs when available. As part of the National Strategic Plan to improve quality of healthcare services, the DoH has rolled out District Clinical Specialist Teams (DCST) including a family physician, paediatrician, anaesthetist, midwife and obstetrician. However the success of staff recruitment to the DCST has been varied. Finally, a local scoping study (unpublished data) of healthcare staff demonstrated gaps in training, supervision and retention of staff with consequent impact on healthcare worker motivation and performance.
STUDY HYPOTHESIS AND JUSTIFICATION Given the nature of overstretched health services, gaps in the PMTCT cascade and infant nutrition illustrated above, a QI intervention is considered most appropriate for optimising clinic processes and therefore healthcare outcomes. It is anticipated that through a real time data-driven approach, process outcomes can be continuously monitored, thereby motivating long term sustainability of changes in clinical practice and improving provider and patient satisfaction with services. Furthermore, QI is a strategy the South African DoH is committed to, as part of improving quality of health services and has worked on several projects with the Centre for Rural Health (CRH), University of KwaZulu-Natal.
The investigators believe this is the first study to causally assess the impact of QI on specified health care outcomes, utilizing a randomised controlled trial (stepped-wedge) study design.
- Being tested
- Quality Improvement, Baseline data collection (active comparator)
- Keywords
- postnatal
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Quality ImprovementOther
In a stepped wedge fashion all 7 PHC clinics will receive QI one by one (exception: the two smallest clinics will be rolled into one step). Each step is of 2 months' duration. The study will commence with baseline data collection across all clinics, before the first randomised clinic receives the QI intervention. The QI intervention involves the following activities at each clinic: [1] Situational Analysis: assessment of clinic needs and gaps in processes that influence the specified study endpoints; [2] Intensive Intervention Phase (2 months): the clinic QI team (healthcare facility staff) with support of CRH QI mentors maps clinic processes and establishes priorities for process improvements through identification of bottlenecks, root-causes and commence plan-do-study-act (PDSA) cycles; [3] Maintenance Phase (duration varies for each clinic based on stepped wedge study design): clinic processes are further improved through iterative PDSA cycles; [4] Follow up.
Baseline data collection (active comparator)Other
Endpoint data collection only
| Study group | Role | What they receive |
|---|---|---|
| Receiving/ received QI intervention | Experimental | A clinic which is presently receiving the Intensive Phase of the QI intervention, or is in the Maintenance Phase Receives: Other: Quality Improvement |
| Not yet received QI intervention | Active comparator | A clinic which has not yet received the QI intervention Receives: Other: Baseline data collection (active comparator) |
What is being measured
The primary outcome is the main question the study is designed to answer.
Proportion of HIV-infected pregnant women who are on ART and have received an HIV VL test
Measured: At study mid-point and study end (approximately 20 months)
Proportion of women who are HIV-uninfected at first ANC HIV test with a repeat antenatal HIV test
Measured: At study mid-point and study end (approximately 20 months)
Secondary outcomes (12)
Proportion of HIV-infected pregnant women who have HIV virologic suppression
Measured: At study mid-point and study end (approximately 20 months)
Uptake of exclusive breastfeeding
Measured: At study mid-point and study end (approximately 20 months)
Uptake of contraception
Measured: At study mid-point and study end (approximately 20 months)
Proportion of HIV-infected women initiated on ART during pregnancy/breastfeeding (PMTCT)
Measured: At study mid-point and study end (approximately 20 months)
Number of participants with knowledge of early infant feeding
Measured: At study mid-point and study end (approximately 20 months)
Number of participants with knowledge of available contraception
Measured: At study mid-point and study end (approximately 20 months)
Number of participants with knowledge of HIV
Measured: At study mid-point and study end (approximately 20 months)
Subjective experience: patient satisfaction with services
Measured: At study mid-point and study end (approximately 20 months)
Subjective experience: provider job satisfaction and motivation
Measured: At study mid-point and study end (approximately 20 months)
Proportion of infant HIV PCR positivity among HIV-exposed infants (HEI)
Measured: At study mid-point and study end (approximately 20 months)
Proportion of HEI receiving nevirapine prophylaxis
Measured: At study mid-point and study end (approximately 20 months)
Proportion of participants enrolled at delivery attending 6-week postnatal visit
As a measure of retention in care at 6 weeks postpartum
Measured: At study mid-point and study end (approximately 20 months)
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted10 Dec 2015 (estimated)
- Study start15 Jul 2015
- Primary completion26 Jan 2017
- Study completion30 Jan 2017
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (18)Papers the sponsor has linked to this study.
- Other trials for PregnancyStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Health services research
- Allocation
- Randomised
- Intervention model
- Single group
- Model description
- Stepped wedge trial: therefore all clusters receive intervention, in randomised sequence.
- Masking
- Single blind
- Who is masked
- Care provider
- Enrolment
- 3,172 participants (actual)
Sponsor and investigators
- Lead sponsor
- University of KwaZulu
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- Till Barnighausen, MD, ScD, Principal investigator, Africa Centre for Population Health, University of KwaZulu-Natal
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT02626351
- Sponsor's protocol ID
- EuropeAid/134286/L/ACT/ZA
- Acronym
- MONARCH
- Status last verified
- Dec 2015
- First submitted
- 23 Oct 2015
- Last updated
- 17 Aug 2017
- Results posted
- No
- Data monitoring committee
- Yes
Publications
Bardfield J, Agins B, Palumbo M, Wei AL, Morris J, Marston B; Cotrimoxazole Qi Group. Improving rates of cotrimoxazole prophylaxis in resource-limited settings: implementation of a quality improvement approach. Int J Qual Health Care. 2014 Dec;26(6):613-22. doi: 10.1093/intqhc/mzu085. Epub 2014 Oct 21.
PubMed 25335758Barron P, Pillay Y, Doherty T, Sherman G, Jackson D, Bhardwaj S, Robinson P, Goga A. Eliminating mother-to-child HIV transmission in South Africa. Bull World Health Organ. 2013 Jan 1;91(1):70-4. doi: 10.2471/BLT.12.106807. Epub 2012 Nov 19.
PubMed 23397353Doherty T, Chopra M, Nsibande D, Mngoma D. Improving the coverage of the PMTCT programme through a participatory quality improvement intervention in South Africa. BMC Public Health. 2009 Nov 5;9:406. doi: 10.1186/1471-2458-9-406.
PubMed 19891775Kim YM, Banda J, Kanjipite W, Sarkar S, Bazant E, Hiner C, Tholandi M, Reinhardt S, Njobvu PD, Kols A, Benavides B. Improving performance of Zambia Defence Force antiretroviral therapy providers: evaluation of a standards-based approach. Glob Health Sci Pract. 2013 Aug 14;1(2):213-27. doi: 10.9745/GHSP-D-13-00053. eCollection 2013 Aug.
PubMed 25276534Maman D, Huerga H, Mukui I et al (2015). Most Breastfeeding Women with High Viral Load Are Still Undiagnosed in Sub-Saharan Africa. Conference on Retroviruses and Opportunistic Infections. Abstract number 32. Available at: http://www.croiconference.org/sessions/most-breastfeeding-women-high-viral-load-are-still-undiagnosed-sub-saharan-africa
Mwaniki MK, Vaid S, Chome IM, Amolo D, Tawfik Y; Kwale Improvement Coaches. Improving service uptake and quality of care of integrated maternal health services: the Kenya Kwale District improvement collaborative. BMC Health Serv Res. 2014 Sep 21;14:416. doi: 10.1186/1472-6963-14-416.
PubMed 25240834Massyn N, Day C, Peer N et al eds (2013/14). District Health Barometer Durban: Health Systems Trust; October 2014.
Mutiso P, Simba M, Towett R et al (2014). Effective monitoring of HIV prevention: re-testing HIV-negative clients. 20th International AIDS Conference, Melbourne Australia. Abstract number WEPE178. Available at: http://pag.aids2014.org/abstracts.aspx?aid=7817
Statistics South Africa (2014). Mid-Year Population Estimates. Available at: http://www.statssa.gov.za/publications/P0302/P03022014.pdf
UNFPA South Africa (2014). Sexual and Reproductive Health. Available at: http://countryoffice.unfpa.org/southafrica/2011/11/24/4255/reproductive_health_and_hiv/
UNICEF (2012). UNICEF and WHO welcome South Africa's efforts to protect and support breastfeeding. Available at: http://www.unicef.org/southafrica/media_10469.html
Webster PD, Sibanyoni M, Malekutu D, Mate KS, Venter WD, Barker PM, Moleko W. Using quality improvement to accelerate highly active antiretroviral treatment coverage in South Africa. BMJ Qual Saf. 2012 Apr;21(4):315-24. doi: 10.1136/bmjqs-2011-000381.
PubMed 22438327WHO publications (2014). Global Update on the Health Sector Response to HIV. Available at http://www.who.int/hiv/pub/progressreports/update2014/en/
WHO publications (2015). Consolidated Guidelines on HIV Testing Services. Available at: http://www.who.int/hiv/pub/guidelines/hiv-testing-services/en/
Zaidi J, Grapsa E, Tanser F, Newell ML, Barnighausen T. Dramatic increase in HIV prevalence after scale-up of antiretroviral treatment. AIDS. 2013 Sep 10;27(14):2301-5. doi: 10.1097/QAD.0b013e328362e832.
PubMed 23669155
Study at a glance
From the registry record, last updated by the sponsor on 17 Aug 2017. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Optimizing the Delivery of Maternal and Child Health Services to Strengthen the Primary Health Care System in Rural South Africa
- ClinicalTrials.gov ID
- NCT02626351
- Acronym / sponsor ID
- MONARCH / EuropeAid/134286/L/ACT/ZA
- Keywords
- postnatal
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 3,172 participants (actual)
- Lead sponsor
- University of KwaZuluUniversity, hospital or other
- Study start
- 15 Jul 2015 (actual)
- Primary completion
- 26 Jan 2017 (actual)
- Study completion
- 30 Jan 2017 (actual)
- First posted
- 10 Dec 2015 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study evaluates the impact of a quality improvement (QI) intervention on maternal and child healthcare services in seven primary healthcare (PHC) clinics, in a rural setting of KwaZulu-Natal, South Africa.
Detailed description
INTRODUCTION TO QUALITY IMPROVEMENT Quality Improvement (QI), defined as "systematic and continuous actions that lead to measurable improvement in health care services and the health status of targeted patient groups" (IOM 2014) has roots in the consumer industry as far back as the 1920s. Data-driven structured process improvements have their origins in the consumer industry, particularly motor vehicles, and Avedis Donabedian first described a model for healthcare quality improvement in the 1960s which reflects the same process change model utilised in the consumer industry: the key elements being structures, processes and outcomes. Don Berwick and colleagues founded the Institute for Healthcare Improvement (IHI) in the 1990s, now a leading institution on QI worldwide. The QI approach or 'form' is structured and uses specific QI tools, whereas its application or 'function' is varied depending on selected process interventions and local context. Given the move towards rigorously improving quality of health care worldwide, QI methodology is increasingly gaining popularity not only in high-income settings but also in low- and middle-income countries (LMIC) including South Africa through Department of Health (DoH) commitments to improving quality of health care and reducing disparities thereof.
EVIDENCE BASE FOR QI Whereas QI is increasingly used worldwide including resource-rich settings and resource-limited settings, there is a paucity of scientific evidence assessing causal impact of QI on health outcomes, particularly the gold standard randomized controlled trial. Studies in resource-limited settings suggest a beneficial effect of QI on measured healthcare outcomes however none assessed QI rigorously as a single intervention.
GAPS IN THE PMTCT CASCADE AND INFANT NUTRITION Despite worldwide rollout of antiretroviral therapy (ART) and efforts to prevent mother-to-child transmission (PMTCT), there are still large gaps in coverage with approximately 240,000 infants vertically infected with HIV worldwide, 89% of whom were from the WHO Africa region. South Africa has a very high prevalence of HIV, with a national average of 30% amongst antenatal care (ANC) clients. In the Africa Centre Demographic Surveillance Area (DSA) located within the Hlabisa sub-district of uMkhanyakude district, the HIV prevalence amongst females of reproductive age (15-49 years) ranged from 20-45% in 2011.KwaZulu-Natal province had the highest prevalence of HIV amongst ANC clients of 37.4% in 2012. Furthermore, although KwaZulu-Natal (KZN) had the highest rate of ART coverage amongst HIV-infected pregnant women eligible for ART, the uMkhanyakude district in KZN had ART coverage of only 73% during the same period, far behind the national target of 90%.
Studies have shown inadequate virologic suppression amongst HIV-infected pregnant and breastfeeding (PBF) mothers, and inadequate repeat HIV testing of HIV-negative mothers during the PBF period. Surveillance of PBF mothers in Kenya, Malawi and South Africa demonstrated an HIV seroconversion rate of approximately 4%, illustrating the need to repeat HIV testing through pregnancy and breastfeeding in order to minimize risk of MTCT. Moreover the rate of virologic suppression amongst HIV-infected PBF women varied from 27% (in Kenya) to 72% in Malawi in the same study, and underscores the importance of virologic monitoring to reduce MTCT through virologic suppression. A study in Kenya demonstrated a repeat HIV testing rate of approximately 23% in HIV negative mothers. Given the risk of seroconversion during PBF, the World Health Organisation recommends repeat HIV screening during PBF in high prevalence settings. Although SA has achieved a commendable reduction in MTCT to 2.7% in 2011 at 6 weeks of age in line with the UNAIDS call for virtual elimination of MTCT by 2015, these gaps in PMTCT coverage increase the risk of undetected maternal HIV seroconversion and inadequate virologic suppression and therefore PMTCT achievements to date may be reversed without adequate intervention. Furthermore, given the fertility rate of the population, an MTCT rate of 2.7% with an antenatal HIV prevalence of 30% the number of new infant infections per year in South Africa is concerning high. Preliminary data from the Africa Centre suggest that less than 40% HIV-negative pregnant women undergo re-testing for HIV during pregnancy, whilst approximately 10-20% on lifelong ART (initiated prior to or during the current pregnancy) have virologic failure.
An important component on the agenda for reducing maternal morbidity and mortality is preventing unwanted pregnancies through better uptake of family planning methods. However limitations to contraceptive uptake include lack of knowledge and lack of access in resource-limited settings. According to UNFPA estimates, contraceptive prevalence in South Africa is approximately 65% despite free access to most methods.
Although replacement feeding of HIV-exposed infants might mitigate the risk of MTCT, in resource-limited settings with unreliable access to safe drinking water the high risk of childhood illnesses such as diarrhoea and pneumonia is associated with high rates of mortality. As under 5 childhood mortality in these settings can be reduced significantly by exclusive breastfeeding (EBF), the WHO recommends EBF for HIV-infected and HIV-uninfected mothers, whilst the importance of ART and virologic suppression are further emphasised. These recommendations are endorsed by the South African DoH however stigma associated with EBF by HIV-infected mothers often becomes a barrier to uptake of EBF in general. South Africa had the lowest rates of EBF in the world in 2012 at just 8%.
New South African DoH ART guidelines were implemented in January 2015, notably changing PMTCT guidance to Option B+ (lifelong ART for all pregnant women regardless of CD4 count). HIV screening every 3 months during PBF is also recommended due to the risk of seroconversions given the high prevalence of HIV in South Africa. Furthermore, viral load (VL) testing of PBF on ART is recommended, immediately for those already on ART prior to pregnancy and every 6 months thereafter (assuming VL results are <1000 copies/mL); newly diagnosed PBF women should receive a VL test 3 months after initiating ART and 6 monthly thereafter (assuming VL results are <1000 copies/mL).
THE CONTEXT OF ANTENATAL AND POSTNATAL CARE SERVICES The Africa Centre for Population Health is located in the Hlabisa sub-district of uMkhanyakude district in rural KwaZulu-Natal South Africa. The Africa Centre Demographic Surveillance Area (DSA) covers an area of 438 km2 and is home to the Africa Centre Household Demographic Surveillance System (HDSS), covering approximately 90,000 people from 11,000 households annually. The HDSS is a longitudinal cohort from the early 2000s and collects individual and household information on mortality, fertility, migration, health status and socio-economic data. This provides a nuanced understanding of the study population and enables linking of datasets.
There are 7 primary healthcare clinic (PHC) facilities which are nurse-led in the DSA, providing ANC, PNC and other medical services, and one local district hospital (Hlabisa hospital) which offers some tertiary care services including routine and emergency obstetric care. The number of deliveries occurring in Hlabisa sub-district is estimated at about 3000 per annum.
The local hospital also provides medical doctor support to the PHCs when available. As part of the National Strategic Plan to improve quality of healthcare services, the DoH has rolled out District Clinical Specialist Teams (DCST) including a family physician, paediatrician, anaesthetist, midwife and obstetrician. However the success of staff recruitment to the DCST has been varied. Finally, a local scoping study (unpublished data) of healthcare staff demonstrated gaps in training, supervision and retention of staff with consequent impact on healthcare worker motivation and performance.
STUDY HYPOTHESIS AND JUSTIFICATION Given the nature of overstretched health services, gaps in the PMTCT cascade and infant nutrition illustrated above, a QI intervention is considered most appropriate for optimising clinic processes and therefore healthcare outcomes. It is anticipated that through a real time data-driven approach, process outcomes can be continuously monitored, thereby motivating long term sustainability of changes in clinical practice and improving provider and patient satisfaction with services. Furthermore, QI is a strategy the South African DoH is committed to, as part of improving quality of health services and has worked on several projects with the Centre for Rural Health (CRH), University of KwaZulu-Natal.
The investigators believe this is the first study to causally assess the impact of QI on specified health care outcomes, utilizing a randomised controlled trial (stepped-wedge) study design.
Study design
- Primary purpose
- Health services research
- Allocation
- Randomised
- Intervention model
- Single group
- Masking
- Single blind (care provider)
- Number of arms
- 2
- Model description
- Stepped wedge trial: therefore all clusters receive intervention, in randomised sequence.
| Arm | Type | Receives |
|---|---|---|
| Receiving/ received QI intervention | Experimental | Other: Quality ImprovementA clinic which is presently receiving the Intensive Phase of the QI intervention, or is in the Maintenance Phase |
| Not yet received QI intervention | Active comparator | Other: Baseline data collection (active comparator)A clinic which has not yet received the QI intervention |
Who may qualify
- Ages
- 18 to 50 years
- Sex
- Female only
- Healthy volunteers
- Accepted
- Age groups
- Adult
Key inclusion criteria (3 listed)
- Currently postpartum: immediately post delivery OR 3-6 days postpartum OR 6 weeks postpartum; AND
- Lives in Africa Centre Demographic Surveillance Area (DSA); AND/OR
- Attended antenatal care (ANC) or postnatal care (PNC) in study intervention clinics
Key exclusion criteria (4 listed)
- Below 18 years of age;
- Not postpartum;
- Does not live within Africa Centre DSA; AND
- Did not attend ANC or PNC at study intervention clinics
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Quality ImprovementIn a stepped wedge fashion all 7 PHC clinics will receive QI one by one (exception: the two smallest clinics will be rolled into one step). Each step is of 2 months' duration. The study will commence with baseline data collection across all clinics, before the first randomised clinic receives the QI intervention. The QI intervention involves the following activities at each clinic: [1] Situational Analysis: assessment of clinic needs and gaps in processes that influence the specified study endpoints; [2] Intensive Intervention Phase (2 months): the clinic QI team (healthcare facility staff) with support of CRH QI mentors maps clinic processes and establishes priorities for process improvements through identification of bottlenecks, root-causes and commence plan-do-study-act (PDSA) cycles; [3] Maintenance Phase (duration varies for each clinic based on stepped wedge study design): clinic processes are further improved through iterative PDSA cycles; [4] Follow up. | Other | Receiving/ received QI intervention |
| Baseline data collection (active comparator)Endpoint data collection only | Other | Not yet received QI intervention |
Primary outcome
Proportion of HIV-infected pregnant women who are on ART and have received an HIV VL test
Time frame: At study mid-point and study end (approximately 20 months)
Proportion of women who are HIV-uninfected at first ANC HIV test with a repeat antenatal HIV test
Time frame: At study mid-point and study end (approximately 20 months)
12 secondary outcomes
Proportion of HIV-infected pregnant women who have HIV virologic suppression
Time frame: At study mid-point and study end (approximately 20 months)
Uptake of exclusive breastfeeding
Time frame: At study mid-point and study end (approximately 20 months)
Uptake of contraception
Time frame: At study mid-point and study end (approximately 20 months)
Proportion of HIV-infected women initiated on ART during pregnancy/breastfeeding (PMTCT)
Time frame: At study mid-point and study end (approximately 20 months)
Number of participants with knowledge of early infant feeding
Time frame: At study mid-point and study end (approximately 20 months)
Number of participants with knowledge of available contraception
Time frame: At study mid-point and study end (approximately 20 months)
Number of participants with knowledge of HIV
Time frame: At study mid-point and study end (approximately 20 months)
Subjective experience: patient satisfaction with services
Time frame: At study mid-point and study end (approximately 20 months)
Subjective experience: provider job satisfaction and motivation
Time frame: At study mid-point and study end (approximately 20 months)
Proportion of infant HIV PCR positivity among HIV-exposed infants (HEI)
Time frame: At study mid-point and study end (approximately 20 months)
Proportion of HEI receiving nevirapine prophylaxis
Time frame: At study mid-point and study end (approximately 20 months)
Proportion of participants enrolled at delivery attending 6-week postnatal visit
Time frame: At study mid-point and study end (approximately 20 months)
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 17 Aug 2017.
- Background: PubMed 25335758Bardfield J, Agins B, Palumbo M, Wei AL, Morris J, Marston B; Cotrimoxazole Qi Group. Improving rates of cotrimoxazole prophylaxis in resource-limited settings: implementation of a quality improvement approach. Int J Qual Health Care. 2014 Dec;26(6):613-22. doi: 10.1093/intqhc/mzu085. Epub 2014 Oct 21.
- Background: PubMed 23397353Barron P, Pillay Y, Doherty T, Sherman G, Jackson D, Bhardwaj S, Robinson P, Goga A. Eliminating mother-to-child HIV transmission in South Africa. Bull World Health Organ. 2013 Jan 1;91(1):70-4. doi: 10.2471/BLT.12.106807. Epub 2012 Nov 19.
- Background: PubMed 19891775Doherty T, Chopra M, Nsibande D, Mngoma D. Improving the coverage of the PMTCT programme through a participatory quality improvement intervention in South Africa. BMC Public Health. 2009 Nov 5;9:406. doi: 10.1186/1471-2458-9-406.
- Background: PubMed 25276534Kim YM, Banda J, Kanjipite W, Sarkar S, Bazant E, Hiner C, Tholandi M, Reinhardt S, Njobvu PD, Kols A, Benavides B. Improving performance of Zambia Defence Force antiretroviral therapy providers: evaluation of a standards-based approach. Glob Health Sci Pract. 2013 Aug 14;1(2):213-27. doi: 10.9745/GHSP-D-13-00053. eCollection 2013 Aug.
- BackgroundMaman D, Huerga H, Mukui I et al (2015). Most Breastfeeding Women with High Viral Load Are Still Undiagnosed in Sub-Saharan Africa. Conference on Retroviruses and Opportunistic Infections. Abstract number 32. Available at: http://www.croiconference.org/sessions/most-breastfeeding-women-high-viral-load-are-still-undiagnosed-sub-saharan-africa
- Background: PubMed 25240834Mwaniki MK, Vaid S, Chome IM, Amolo D, Tawfik Y; Kwale Improvement Coaches. Improving service uptake and quality of care of integrated maternal health services: the Kenya Kwale District improvement collaborative. BMC Health Serv Res. 2014 Sep 21;14:416. doi: 10.1186/1472-6963-14-416.
- BackgroundMassyn N, Day C, Peer N et al eds (2013/14). District Health Barometer Durban: Health Systems Trust; October 2014.
- BackgroundMutiso P, Simba M, Towett R et al (2014). Effective monitoring of HIV prevention: re-testing HIV-negative clients. 20th International AIDS Conference, Melbourne Australia. Abstract number WEPE178. Available at: http://pag.aids2014.org/abstracts.aspx?aid=7817
- BackgroundStatistics South Africa (2014). Mid-Year Population Estimates. Available at: http://www.statssa.gov.za/publications/P0302/P03022014.pdf
- BackgroundUNFPA South Africa (2014). Sexual and Reproductive Health. Available at: http://countryoffice.unfpa.org/southafrica/2011/11/24/4255/reproductive_health_and_hiv/
- BackgroundUNICEF (2012). UNICEF and WHO welcome South Africa's efforts to protect and support breastfeeding. Available at: http://www.unicef.org/southafrica/media_10469.html
- Background: PubMed 22438327Webster PD, Sibanyoni M, Malekutu D, Mate KS, Venter WD, Barker PM, Moleko W. Using quality improvement to accelerate highly active antiretroviral treatment coverage in South Africa. BMJ Qual Saf. 2012 Apr;21(4):315-24. doi: 10.1136/bmjqs-2011-000381.
Related trials for Pregnancy
Recruiting
Methylation Profiling in Self-Samples for Identification of (Epi)Genetic Biomarkers for Gynecological Cancers
Gynaecological Cancers, Ovarian Cancer
RecruitingPhase 1/2
Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
Solid Tumor, Non-Small Cell Lung Cancer
RecruitingObservational study
Population Pharmacokinetics of Temocillin in Acute Enterobacterial Pyelonephritis in Children
Pyelonephritis
Active, not recruitingPhase 3
A Study of Belzutifan (MK-6482) in Combination With Lenvatinib Versus Cabozantinib for Treatment of Renal Cell Carcinoma (MK-6482-011)
Carcinoma, Renal Cell
Recruiting
Safety and Performance of UCon Patch Electrode
Urinary Incontinence, Urinary Incontinence, Urge
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Till Barnighausen, MD, ScD principal investigator
Africa Centre for Population Health, University of KwaZulu-Natal
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Quality Improvement and Baseline data collection (active comparator) in people with Pregnancy and HIV, run by University of KwaZulu at 1 site in South Africa.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 17 Aug 2017. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in South Africa. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Proportion of HIV-infected pregnant women who are on ART and have received an HIV VL test (time frame: At study mid-point and study end (approximately 20 months)). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT02626351, which also lists 18 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 17 Aug 2017.